Quantbot Technologies LP Compugen LTD Call Options Transaction History
Quantbot Technologies LP
- $2.88 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding CGEN
# of Institutions
80Shares Held
16.5MCall Options Held
28.7KPut Options Held
48.3K-
Silverarc Capital Management, LLC2.9MShares$4.05 Million1.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.4MShares$1.95 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.39MShares$1.94 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.05MShares$1.47 Million0.94% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.43 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $121M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...